TrialBritish journal of clinical pharmacology2017

Exposure-response analysis after subcutaneous administration of RBP-7000, a once-a-month long-acting Atrigel formulation of risperidone.

Vijay Ivaturi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.